Ignite Creation Date:
2024-05-06 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 2:51 PM
Study NCT ID:
NCT05723991
Status:
RECRUITING
Last Update Posted:
2023-02-13
First Post:
2023-02-01
Brief Title:
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
Sponsor:
Organization:
Tongji Hospital